News
April 22 (Reuters) - Drugmaker Bristol Myers Squibb (BMY.N), opens new tab said it has signed a $380 million deal with contract manufacturer Cellares to manufacture its CAR-T cell therapies in the ...
Hosted on MSN16d
Bristol 7 Brew expected to open this summerBRISTOL, Tenn. (WJHL ... aims to give Southwest Virginia children school supplies 7 Brew has more than 380 stands across the country and offers more than 20,000 combinations of coffees ...
Construction is moving forward on two new additions to the Volunteer Parkway corridor — a 7 Brew coffee stand and a Weigel’s convenience store — both of which are expected ...
(Reuters) -Drugmaker Bristol Myers Squibb said it has signed a $380 million deal with contract manufacturer Cellares to manufacture its CAR-T cell therapies in the United States, EU and Japan.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results